The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  EXACT Sciences Corp. (EXAS)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
BioMedReports.com Most Popular Links

Apr 09, 2009 11:55 AM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

The following are links to the most viewed articles and stock research reports at BioMedReports.com since the site was launched earlier this year:

Stock Research Reports - Cytori Therapeutics ( CYTX ), NIVS IntelliMedia ( NIV ):

http://biomedreports.com/research/cat_view/41-stock-research-...

FDA and Clinical Trial Calendars:

http://biomedreports.com/fda-calendar.html

A Resurgence in Cell Therapeutics ( CTIC ):

http://biomedreports.com/articles/most-popular/752-a-resurgen...

Electro-Optical Sciences ( MELA ): Corp. Presentation Summary:

http://biomedreports.com/articles/most-popular/696-electro-op...

Unilife ( UNIFF.PK ) ( UNI.AX ): Making Syringes Safer, Relocating to U.S.

http://biomedreports.com/articles/most-popular/731-unilife-ma...

Analysis of Stem Cell Index YTD:

http://biomedreports.com/articles/most-popular/594-analysis-o...

BioDelivery Sciences ( BDSI ): A Bet on FDA Approval of Onsolis:

http://biomedreports.com/articles/most-popular/597-biodeliver...

EXACT Sciences ( EXAS ) Announces New Management Team:

http://biomedreports.com/blog/EXACT-Sciences-Announces-New-Ma...

Momenta Pharma's ( MNTA ) Three-Part Strategy:

http://biomedreports.com/blog/Momenta-Pharmas-Three-Part-Stra...

Caraco Pharma ( CPD ) Awaits FDA Inspection in May:

http://biomedreports.com/blog/Caraco-Pharma-Awaits-FDA-Inspec...

ImmunoCellular Therapeutics ( IMUC.OB ): Targeting Cancer Stem Cells:

http://biomedreports.com/articles/most-popular/746-immunocell...


EXAS:  This call was made on 04/09/09 @ $1.1
Rating:   Positive   $1.1 (04/09/09)
Closed:   04/12/2009 @ $1.06 (-3.64% in 3 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +35.25% 368
2 18.14 +70.90% 206
3 17.66 +25.78% 53
4 13.47 +14.32% 60
5 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
EXACT Sciences Corp. (EXAS)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
EXAS Positive -0.76% 11/07/09
NFES N/A Positive n/a 11/07/09
IMUC N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -0.53% 11/04/09

View All >
   
Mike Havrilla previously rated EXAS
Positive -0.76% EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside
11/07/2009
9
Positive +6.48% EXACT Sciences (NASDAQ: EXAS): Patience Required for Long-Term Upside
11/03/2009
9
Positive -0.81% BioMed News Bytes: Rockwell Medical, EXACT Sciences, MannKind
10/29/2009
9
Positive -9.45% BioMed News Bytes: Cytori, EXACT Sciences, HEPI
10/03/2009
9
Positive -6.46% Rodman Conference Recaps: EXACT Sciences, Delcath, Unilife
09/13/2009
9
Positive +13.51% EXACT Sciences: Smaller Phase 3 Study Will Save Time, Money
08/14/2009
9
Positive -8.16% New Indexes to Track Healthcare Trends and More
08/04/2009
9
Positive +1.44% EXACT Sciences: FDA-Cleared Test Key to Future Earnings
08/01/2009
9
Positive +1.46% EXACT Sciences (NASDAQ:EXAS): Back on Track, Report Available
07/15/2009
9
Positive +158.49% New Index of Cancer Diagnostic and Therapeutic Stocks
04/12/2009
9
Positive -7.56% BioMed Stock Movers: DNDN, EXAS, KG
04/08/2009
9
Positive +19.00% EXACT Sciences Announces New Management Team
03/18/2009
1
Positive -40.83% EXACT Sciences Forms Pact with Genzyme
01/28/2009
9
Positive +14.18% Healthcare Hot Spots Beyond Stem Cells
01/26/2009
9
Positive -0.66% New Preventive Medicine Index
01/25/2009
9
Positive +7.97% Create Your Own Diagnostics ETF
01/20/2009
9
Positive -8.00% EXACT Sciences Rejects Sequenom's $41M Offer
01/12/2009
9
Positive +0.00% EXACT
01/12/2009
9
Positive -0.66% Analyzing Sequenom's Offer for EXACT Sciences
01/12/2009
9
Positive +8.63% Buyout Binge Begins for Bio-Pharma, Diagnostics
01/10/2009
1
Positive +152.73% A New Emerging Diagnostics Index
12/26/2008
1
Positive -35.29% EXACT Sciences Next Generation Stool-Based DNA Technology Outperforms Blood Plasma Testing
08/08/2008
3
Positive +19.70% ColoSure & Cost Reductions Key to EXACT's Future
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch